These studies started years ago. Yep, agree on drug effect differences

That's also the key difference too --- getting results on using LAL + AAV Vector delivery

Then piggybacking into LL-PLS/Vector for the FcRn & cancer patent also....i would think Hiv-MDR has less competitors

I think his work is not for Cytodyn to go into Hiv themselves or at least even alone